The specific role of isoflavones in reducing prostate cancer risk.
about
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell lineA systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortalityNutritional translation blended with food science: 21st century applicationsIsoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteersResults of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.Recent progress on nutraceutical research in prostate cancer.Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures.Botanical medicine and cancer: a review of the safety and efficacy.Role of vitamins, minerals and supplements in the prevention and management of prostate cancer.Clinical trials of natural products as chemopreventive agents for prostate cancer.Isoflavones and Prostate Cancer: A Review of Some Critical Issues.A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.Safety of purified isoflavones in men with clinically localized prostate cancerA review of phase III clinical trials of prostate cancer chemoprevention.Soy isoflavone genistein in prevention and treatment of prostate cancer.Natural products for cancer preventionDietary interventions in prostate cancerPerspectives on the role of isoflavones in prostate cancer.Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.Analytical and compositional aspects of isoflavones in food and their biological effects.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Risks and benefits of dietary isoflavones for cancer.Prostate cancer and diet: food for thought?Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.Does equol production determine soy endocrine effects?Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies.STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.Chemoprevention of prostate cancer: soy isoflavones and curcumin.A phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer.Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer.Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.
P2860
Q25256692-71BF035B-2672-427F-B1B0-5C7839DA527AQ26782066-91015D2D-18DA-41F6-A8DC-AEA17C615FA0Q26849431-C02F6172-8390-469B-BDBF-6BF972136579Q33710326-E79A1B5C-A859-40E3-8C54-8C021D0845A1Q33757794-50ADCDE1-01AE-4172-94AF-B14F590C004AQ33818800-DEB75DCE-C6B5-45DB-9E9D-9CEF609E0EC9Q34848018-A71E41E7-A7AD-4312-A521-46F399164575Q34976272-30763208-B6DE-4D25-A7F4-8B060AC385B8Q34992997-C83E8E4C-959F-42C8-AE64-2500E3AC3593Q35196710-C079C866-E3F1-4707-8341-F4592CF01B6FQ35752245-FDFBBFCA-E2BC-48DE-BB4B-AF60462176AEQ35823852-BEB98EAB-930D-449E-89A1-8AC3E5CD4976Q35967334-02713FB6-B484-479E-862A-47B8E57CB179Q36414920-51C9BA1D-6337-4B6B-AF4F-10506647E9AEQ36600291-91ED143C-7B51-40FB-B05A-FD0941F6B039Q36705608-8CF814BF-315F-4DAF-9529-E14C6325B6D3Q36732271-3DB3FC65-EA26-4760-B387-7C68BEF2809CQ36741928-665EAED4-1BC1-47A4-A6A3-D66172B75E2CQ36774297-3C71A865-1892-473D-91D3-36B9CA68EC2EQ36965664-62F3A289-3CA7-4023-99D8-6AEB9BDE3C8EQ37109727-9F819639-E7FB-46B7-81CB-B92E730984CAQ37124666-21CAD500-00ED-4CE4-8855-F247E34617CFQ37207772-3D1F0293-6D08-4E4F-BBDD-467D025157D8Q37442309-EA9366FD-CC27-478E-9817-F72969586D1BQ37576761-3C58DAF1-4F46-44E3-82F3-97B2509A5F0DQ37577822-A0C60472-BDE8-4D4C-9DE8-9519152C82D9Q37602049-DA1513F0-4067-4C61-9910-FCF217D7C993Q37654590-3F76F961-4ACE-482B-9C93-22E44E74EBF8Q37857841-613B86D8-64C8-4121-813F-9D9B629198FDQ37868753-BD319312-61E6-4A1F-92E9-439DC7E84FEDQ37944367-AA5080CA-49C5-41DE-81F5-AA4374016C40Q37988309-717BA06A-EA48-4FF3-AD51-797FB9D5DFCAQ38245598-FC0ADDD5-EE0A-40CC-A152-87863AAC7EE7Q38558029-CB322266-C0B7-4E85-84F1-AFFB779C86ADQ39023307-D8647010-8156-4986-BD51-E076940EA903Q39913846-8FB774CB-5086-4DC7-B2FD-F7C7864E85DDQ41466203-3E2BD5CA-2CBF-40D0-8CD4-8743BEB39E63Q43184865-6752DE13-6E2D-4CF8-A5A8-2DCAE1208211Q44647635-B2D49753-657C-4F24-8FE1-6A7F9508439FQ47107153-0106132D-9D6F-47BE-873E-B050235AE748
P2860
The specific role of isoflavones in reducing prostate cancer risk.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
The specific role of isoflavones in reducing prostate cancer risk.
@ast
The specific role of isoflavones in reducing prostate cancer risk.
@en
The specific role of isoflavones in reducing prostate cancer risk.
@nl
type
label
The specific role of isoflavones in reducing prostate cancer risk.
@ast
The specific role of isoflavones in reducing prostate cancer risk.
@en
The specific role of isoflavones in reducing prostate cancer risk.
@nl
prefLabel
The specific role of isoflavones in reducing prostate cancer risk.
@ast
The specific role of isoflavones in reducing prostate cancer risk.
@en
The specific role of isoflavones in reducing prostate cancer risk.
@nl
P2093
P356
P1433
P1476
The specific role of isoflavones in reducing prostate cancer risk.
@en
P2093
Alan Cantor
Diane Riccardi
John Seigne
Julio Pow-Sang
Karen Besterman-Dahan
Kathy Allen
Mohamad Helal
Nagi B Kumar
Raoul Salup
P2860
P304
P356
10.1002/PROS.10362
P577
2004-05-01T00:00:00Z